Indications
Therapeutic Asset Ratings
6,299 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Vsv-Ifnβ-Nis
Neuroendocrine Carcinoma
Vyriad, Inc.
P1/2
CC
(45)
Vsv-Ifnβ-Nis
Renal Cell Carcinoma
Vyriad, Inc.
P1/2
CC
(45)
Wve-004
Amyotrophic Lateral Sclerosis
Wave Life Sciences USA, Inc.
P1/2
CC
(45)
Xer-001
Pancreatic Adenocarcinoma
Xerient Pharma
P1/2
CC
(45)
xnw27011
Non-Small Cell Lung Carcinoma
Evopoint Biosciences Inc.
P1/2
CC
(45)
xnw27011
Pancreatic Adenocarcinoma
Evopoint Biosciences Inc.
P1/2
CC
(45)
xnw28012
Exocrine Pancreatic Carcinoma
Evopoint Biosciences Inc.
P1/2
CC
(45)
xnw5004
Hepatocellular Carcinoma
Evopoint Biosciences Inc.
P1/2
CC
(45)
xnw5004
Small Cell Lung Carcinoma
Evopoint Biosciences Inc.
P1/2
CC
(45)
xnw5004
Head And Neck Squamous Cell Carcinoma
Evopoint Biosciences Inc.
P1/2
CC
(45)
yh42946
Non-Small Cell Lung Carcinoma
Yuhan Corporation
P1/2
CC
(45)
yl-13027
Cancer
Shanghai YingLi Pharmaceutical Co. Ltd.
P1/2
CC
(45)
yl201
Cancer
MediLink Therapeutics (Suzhou) Co., Ltd.
P1/2
CC
(45)
yl-201
Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(45)
Ysch-01
Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(45)
zg005
Neuroendocrine Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
P1/2
CC
(45)
zg006
Neuroendocrine Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
P1/2
CC
(45)
Zn-D5 Zn-C3
Acute Myeloid Leukemia
K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.
P1/2
CC
(45)
zs801
Hemophilia B
Institute of Hematology & Blood Diseases Hospital, China
P1/2
CC
(45)
Zunsemetinib
Breast Carcinoma
Washington University School of Medicine
P1/2
CC
(45)
Γδ T Cells
Acute Myeloid Leukemia
Chinese PLA General Hospital
P1/2
CC
(45)
68Ga-grazytracer
Cancer
Peking University Cancer Hospital & Institute
P1/2
CC
(44)
a2b395
Triple-Negative Breast Carcinoma
A2 Biotherapeutics Inc.
P1/2
CC
(44)
a2b530
Non-Small Cell Squamous Lung Carcinoma
A2 Biotherapeutics Inc.
P1/2
CC
(44)
a2b543
Pancreatic Neoplasm
A2 Biotherapeutics Inc.
P1/2
CC
(44)
Showing 3926 to 3950 of 6,299 assets
Previous
Page 158 of 252
Next
